Gilead's remdesivir shaved five days off COVID-19 recovery time, reduced risk of death in some
Results of the overall study suggested the drug may reduce mortality, but the benefit was not statistically significant.
Fri Oct 09 2020
Trump to spend days at military hospital after COVID-19 diagnosis
Trump received a first dose of Remdesivir, an intravenous antiviral drug sold by Gilead Sciences Inc.
Sat Oct 03 2020